Homology Medicines CEO Arthur Tzianabos' 2018 pay jumps 79% to $4.3M
Homology Medicines reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Homology Medicines reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, three executives at Homology Medicines received on average a compensation package of $2.9M, a 82% increase compared to previous year.
Average pay of disclosed executives at Homology Medicines
Arthur O. Tzianabos, Chief Executive Officer, received $4.3M in total, which increased by 79% compared to 2017. 83% of Tzianabos' compensation, or $3.6M, was in option awards. Tzianabos also received $250K in non-equity incentive plan, $491K in salary, as well as $9.9K in other compensation.
Tim Kelly, Chief Technical Operations Officer, received a compensation package of $2.2M. 78% of the compensation package, or $1.7M, was in option awards.
Albert Seymour, Chief Scientific Officer, earned $2.1M in 2018, a 181% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2019.